Literature DB >> 30125433

Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin.

E P de Mattos1, V B Leotti2, B-W Soong3, M Raposo4, M Lima4, J Vasconcelos5, H Fussiger6, G N Souza7, N Kersting7, G V Furtado1, J A M Saute7,8, S A Camey2, M L Saraiva-Pereira1,8,9, L B Jardim1,7,8,10.   

Abstract

BACKGROUND AND
PURPOSE: In spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD), the length of CAG repeat expansions in ATXN3 shows an inverse correlation with age at onset (AO). Recently, a formula for predicting AO based on CAG expansion was developed for European carriers. We tested this formula in SCA3/MJD carriers from distinct origins and developed population-specific models to predict AO.
METHODS: This was a parametric survival modelling study.
RESULTS: The European formula (EF) was tested in 739 independent SCA3/MJD carriers from South Brazil, Taiwan and the Portuguese Azorean islands, and it largely underestimated AO in South Brazilian and Taiwanese test cohorts. This finding challenged the universal use of the EF, leading us to develop and validate population-specific models for AO prediction. Using validation cohorts, we showed that Brazilian and Taiwanese formulas largely outperformed the EF in a population-specific manner. Inversely, the EF was more accurate at predicting AO among Portuguese Azorean patients. Hence, specific prediction models were required for each SCA3/MJD ethnic group.
CONCLUSIONS: Our data strongly support the existence of as yet unknown factors that modulate AO in SCA3/MJD in a population-dependent manner, independent of CAG expansion length. The generated models are made available to the scientific community as they can be useful for future studies on SCA3/MJD carriers from distinct geographical origins.
© 2018 EAN.

Entities:  

Keywords:  Machado-Joseph disease; age at onset; genetic modifier; spinocerebellar ataxia type 3; survival models

Mesh:

Year:  2018        PMID: 30125433     DOI: 10.1111/ene.13779

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3.

Authors:  Shi-Rui Gan; Karla P Figueroa; Hao-Ling Xu; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Liana Rosenthal; Tetsuo Ashizawa; Stefan M Pulst; Ning Wang; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2020-02-17       Impact factor: 4.891

2.  Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Rafaella Mergener; Gabriel Vasata Furtado; Eduardo Preusser de Mattos; Vanessa Bielefeldt Leotti; Laura Bannach Jardim; Maria Luiza Saraiva-Pereira
Journal:  Neuromolecular Med       Date:  2019-10-05       Impact factor: 3.843

Review 3.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

4.  State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change.

Authors:  Gabriel Vasata Furtado; Camila Maria de Oliveira; Gabriela Bolzan; Jonas Alex Morales Saute; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Genet Mol Biol       Date:  2019-06-10       Impact factor: 1.771

5.  The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study.

Authors:  Yun Peng; Linliu Peng; Zhao Chen; Huirong Peng; Puzhi Wang; Youming Zhang; Yangping Li; Chunrong Wang; Yuting Shi; Xuan Hou; Zhe Long; Hongyu Yuan; Na Wan; Linlin Wan; Keqin Xu; Lijing Lei; Shang Wang; Lang He; Yue Xie; Yiqing Gong; Qi Deng; Guangdong Zou; Zhichao Tang; Lu Shen; Kun Xia; Rong Qiu; Thomas Klockgether; Beisha Tang; Hong Jiang
Journal:  Front Aging Neurosci       Date:  2022-07-05       Impact factor: 5.702

6.  Explainable artificial intelligence based on feature optimization for age at onset prediction of spinocerebellar ataxia type 3.

Authors:  Danlei Ru; Jinchen Li; Ouyi Xie; Linliu Peng; Hong Jiang; Rong Qiu
Journal:  Front Neuroinform       Date:  2022-08-30       Impact factor: 3.739

7.  Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Gabriela Bolzan; Vanessa Bielefeldt Leotti; Camila Maria de Oliveira; Gabriela Ecco; Amanda Henz Cappelli; Anastacia Guimarães Rocha; Nathalia Kersting; Mariana Rieck; Lucas Schenatto de Sena; Ana Carolina Martins; Maria-Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2021-07-06       Impact factor: 3.847

8.  A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS.

Authors:  Martin Paucar; Per Svenningsson; Jose Miguel Laffita-Mesa; Inger Nennesmo
Journal:  Mov Disord       Date:  2020-10-15       Impact factor: 10.338

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.